THE BRITISH
PAIN SOCIETY
EXPERTISE WHERE IT MATTERS
The British Pain Society
{A company limited by guarantee)
Consolidated Financial Statements
Year ended December 2024
3rd Floor Churchill House
35 Red Lion Square
London
WCIR 4SG
Charity Number: 1103260
Registered Charity in Scotland Number: SC039583
Company Number: 5021381

THE BRITISH PAIN SOCIETY
CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
Page No.
Legal and administrative information
Report of the Directors and Trustees
2-11
Independent Exa miner's report
12
Consolidated Statement of Fina ncial Activities
13
Consolidated and Charity Balance Sheets
14
Consolidated and Charity Statements of Cash Flow5
15
Notes to the Financia I Statements
16-26

THE BRITISH PAIN SOCIETY
LEGAL AND ADMINISTRATIVE INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024
Directors
I"January-5 June 2024
th
5 June 2024- 31" December 2024
Prof R Knaggs
Dr N ColliEhan
President
Interim Honorary
Treasurer
Interim Honorary
Secretary
Dr C Price
Vice President
Dr R Munglani
Vice President
Drs Gulati
Council Member
Dr R Krishnamoorthy Council Member
Ms C Manson
Council Member
Dr D Pang
Council Member
Dr M Chincholkar
Council Membp.r
Dr M sinha
Council Member
Prof. R. Knaggs
Dr N. Collighan
President
Honorary Treasurer
MrMHey
Mrm. Hey
Honorary secretary
Dr C. Price
Dr. R Munglani
Dr. S. Gulati
Dr R. Krishnamoorthy
Dr D. Pang
Dr M. Chincholkar
Dr M. Sinha
Dr l Jones.
Dr S Harrisson
Vice President
Vice President
Council Member
Council Member
Council Member
Council Member
Council Member
Council Meniber
Council Member
*Note thut Ms Cmtlnson ended her term os Council Member on 5June 2024
Note thot Dr l Jone5 and Drs Harrisson begon their term on 5 June 2024
Registered Office:
Third Floorchurchill House
35 Red Lion Square
London WCIR 45G
Bankers..
Ba rclays Bank
Leicester LE87 2BB
Solicitor:
Hempsons Sol icitors
Hempsons House
40 Villiers Street
London WC2N 6NJ
Registered Accountant..
Marcus Cridland B.A.IHonsl F.C.A.
Scott Vever5 Ltd
Chartered Accountants
and Registered Auditors
65 East Street
Bridport DT6 3LB

THE BRITISH PAIN SOCIErY
REPORT OF THE DIREcfoRS AND TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024
The British Pain Society Ithe Societyl is the largest multidisciplinary professional organisation in the field of
pain in the UK. It comprises doctors. nurses, physiotherapists, scientists, psychologists, occupational
therapists, and other healthcare professionals and researchers actively èngaged in the diagnosis and
management of pain and in pain research. As of 31, December 2024, there were 662 members. The Society
is the British Chapter of the International Association for the Study of Pain IIASPI and is part of the European
Federation of IASP Chapters IEFICI.
The wholly owned trading subsidiary 'BPS Pain Business Ltd, was established In September 2014 to run
trading operations on beha If of the Society.
The Directors present their Annual Report and Financial Statements for year ended 31, December 2024.
These financial statements comply with the charitable company's Memorandum and Articles of Association
and applicable laws and regulations Ithe Charities Act 2011, the Companies Act 2006, the Charities and
Trustee I nvestment (Scotlandl Act 2005, regu latioiis 6 a nd 8 of the Charities Accounts Iscotlandl Regulations
2006 and the Charities SORP IFRS 1021 published in October 2019.
1. STRUCTURE, GOVERNANCE AND MANAGEMENT
The British Pai n Society is a company limited by guarantee incorporated on 21" Ja nua ry 2004 and is governed
by its Memorandum and Articles of Association, along with the Regulations last updated on 7, October 2022.
The Direttors are appointed by ballot of the members, except forthe Vice President, Honorary Secretary and
Honorary Treasurer who are appointed by the Directors. Any Ordinary or Honorary Member of the Society
is entitled to stand for election to the post of Directornrustee. Only Members who have previously served
as Trustees of the Pain Society, the British Pain Society, or 35 Board members of either the International
Association for the Study of Pain IIASPI or the European Federation of IASP Chapters IEFICI are eligible to
stand for the post of President, Vice President, Honorary Secretary or Honorary Treasurer, however, if no
person who fa Ils within the eligibility categories is willing to be considered for electioii, Cou ncil may consider
a candidate or candidates from the Ordinary and Honorary Members. All new Directorsnrustees are
required to u ndertake formal induction train ing. Th is is scheduled to take place just before or after their first
Cou ncil Meeting following their appointment.
The Counci l of the Society meets at least four times a yea r. All the decisions related to the management of
the Society are made by the Council at these meetings. The President sets the Agenda for the Council
meeting and takes overall responsibility for the day-to-day ru nning of the Society a long with the Executive
Off icers. There is support for the Council from the following Committees and subcommittees.. Scientific
Programme Committee, Communications Committee, Expert Patient and Carer Committee (previously
named the Patient Voice Committee), Science and Research Committee, Education Committee, and Finance
Committee.
Until the end of October 2022 the Council has been supported by a Secretariat, including a CEO who led the
Secretariat team in the delivery of the Society's objectives a nd projects and contributed to the strategic
planning processes of the Society. From November 2022 onwards the society has enlisted the services of an
Association Management Com pany to provide Secretariat services to the organisation. The Secretariat deals
with the day to day running of the Society, the organisation of the various meetings promoted by the Society
and ma naging the membership of the Society. From April 2024, the society employed an Executive Director
to lead the Secretariat in the co-creation and delivery of the BPS strategy, and to deliver on the society's
objectives and projects. All executive decisions are made by the Council or the Officers, who are the
President, the President-elect lif applica blel, the Vice Pre5identlsl lil a pplicablel the Honorary Treasurer, the
Honorary Treasurer-elect lif applicable), the Honorary Secretary and the Honorary Secretary-elect lif
applica blel and the I mniediate Past President lif applicable), with input f rom the Secretariat.

THE BRITISH PAIN SOCIErY
REPORT OF THE DIRECTORS AND TRUSTEE5
FOR THE YEAR ENDED 31 DECEMBER 2024
An Annual General Meeting of the members is held at the time of the Annua I Scientif ic Meeting and was held
in 2024 at the Annual Scientific Meeting on 5 June 2024.
At the start of 2024 there were twelve Society Special Interest Groups ISIGsl,' Acute Pain, Headache,
I nterventional Pain Medicine, Medicolegal, Neuropathic Pain, Pain in Children, Pain Management
Programmes, Pain Education, Pa in in Older People, Philosophy & Eth ics, Pain i n Developing Cou ntries and
Primary and Community Care. The governance of these groups is established within the Articles and
Regulations of the Society.
Risk Management
The Council has identified areas of risk within the Society and actions that have been taken by Council to
minimise or eliminate these. A business continuity plan was underway in 2024 and work to implement the
identified activities is underway. The specific areas of risk identified are as follows..
Finonciol probity.. The Directors have established systems of internal control, comprising financial
estimates and annual budgets, delegated authorities for operationa I management and segregation of
duties, reviews of financial and investment performance and the identification and managemeiit of risks,
in accordance with the publication CC8 '1 nternal Fi nancial Controls for Charities" The i nternal controls
have been formalised and are set out as Fina nce Procedu res for the Societv.
The internal controls a re subject to ongoing assessment and evaluation by the Directors. At least two
meetings a year are held to consider financial management and performance in detail. The Honorary
Treasurer reports on financial matters to each Council meeting of the Society, comprising Directors and
co-opted members. These meeting5 record the formal review and approval of all aspects of finance,
internal controls. and accou nts.
I n 2024 work continued on improving and sim plifying financial processes and procedures, with an effort
to reduce the complexity of the banking set up. A review of wholly owned trading subsidiary'BPS Pain
Business Ltd, was undertaken to understand the purpose and va lue of this entity. It was decided to begin
closing this entity and manage all trading through the Society. VAT management has been transferred
from 'BPS Pain Business Ltd, to 'The British Pain Society, and steps are in progress to close 'BPS Pain
Busi ness Ltd, and related accounts. The Society will continue looking towards further prudent investment
by spreading risk of funds across additional institutions alongside strea mlin ing financial operations.
Membership Retention.- Further work continues in this area as it reflerts wider challenge5 faced by
professional organisations. Declining membershi p numbers ha5 Stabilised due to the efforts in 2023 and
2024. We have also taken proactive steps to enhance member engagement, introduce new membership
categories including the Early Career and Student membership-and improve the Society's value
proposition. These efforts have helped to stabilise membership numbers and retention, and furtherwork
continues in this area to ensure sustained growth and engagement and future planning to ensure a
younger members are involved in the Society.
Secretariat and Operotiont71 Support.. Continuity in the provision of Secretariat su pport is essential to
allow the Society to deliver planned activities and meet the obligations to its members. 2024 has
provided stability and continuity in secretariat staff, mean ing that all ongoing activities and operations
have progre55ed.
Strategy.. In 2024, tlie Society undertook significant strategic work to refine its strategic priorities,
activities, and future dire.ction. Through a collaborative process involving Trustees. member data, and
key stakeholders, we developed a strategic framework that aligns with our commitment to improving
pain care and advocacy. A key focus has been on strengthening multidisciplinary collaboration,

THE BRITISH PAIN SOCIETY
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024
integrating person-centred care, and enhancing long-term growth. This work has informed our ongoing
initiatives and will guide the Society's activities in the years ahead, ensuring we continue to deliver
meani ngful impact for people living with pa in.
Informotion Technology and Data Protection.. The Society has a website with a built-in database in
operation. Data protection and antiviral systems are in place,. the data is backed up daily. Compliance
with GDPR is assessed regularlyand procedures arein placeto ensure thatthiscompliance is maintained.
Health and Safety
The board accepts formally and publicly its collective role in providing health and safety leadership
in its organisation.
Each mem ber of the board accepts their individual role in providing health and safety leadership for
their organisation.
The board will ensure that all board decisions reflect its hea Ith and safety intentions, as a rticulated
in the health and safety pol icy statement.
The board recognises its role in engagi ng the artive participation of workers in improving health and
safety.
The board will ensure that it is kept informed of and alert to, relevant health and safety risk
management issues. In view of the Health and Safety Commission recommendations, the board will
appoint one of its nu mber to be the 'Health and Safety Director" usua Ily the President.
In line with statutory requirements, the society has Public Liability Insurance, the levels of which are
reassessed on a regular basis.
Involvement with other bodies
The Society is a generic stakeholder for NICE (National Institute for Health and Care Excellencel
gu idelines.
The Society is a generic stakeholder for I nterventional Procedu res and Health Tech nology Assessments
for NICE.
The Society is a member of the Association of Medical Research Charities (AM RCI.
The Society is a generic stakeholder with NHS England Clinical Reference G roups ICRGSI.
The Society ha5 representation on the NHS England Clinical Reference Group for Speciali5ed Pain
services.
A Society member chairs the Healthcare Resource Group working party, with links to the Royal College
of Physicians 'Payment by Results, initiative.
The Society has reciprocal representation on the Board of the Faculty of Pa in Medicine IFPMI.
The Faculty of Pain Medicine of the Royal College of Anaestheti5ts, the Chronic Pain Policy Coalition, the
Royal College of Nursing and the I nternational Association for the Study of Pain IIASPI each have one
representative who sits on the British Pain Society Council as a co-opted member.
The following orga nisations a re also represented at the British Pain Society Council via elected Cou ncil
rnembers who are elected a5 individuals, but who have links with the relevant organisations, The Royal
Pharmaceutica I Society, and the Physiotherapy Pai n Association, the Royal College of Nursiiig, the Faculty
of Pain Medicine, and the Royal College of Gps.
The Society has established a positive relationship with the Depa rtment of Health.
The Society is a member of the Specialised Healthcare Alliance ISHCAI, via its Council CRG liaison officer.
The Society is a member of the Health Conditions in Schools Alliance, via a representative of the Pain in
Children Special Interest Group.
Pain Concern attended the BPS ASM and released a BPS ASM special of their podcast "Airing Pain" with
interview5 from key speakers at the ASM.

THE BRITISH PAIN SOCIETY
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024
The Society has signed a Memorandum of Understanding with both the American Academy of Pain
Medicine and the Canadian Pain Society to ensure communication of each partie5, events and
col laboration on projects of m utual benef it.
The Society continues to endorse the Flippin Pain and EFIC public health campaigns.
2. OBJEcfivES AND AcfiviTIES
The objects as set out i n the Memorandum and Articles for which the Society is established I the Objects I
are the advancement of health by raisingthe standard ofthe managementof pain by promotion of education,
research, and tra ining.
The Directors confirm that they have referred to the Cha rity Commission's general guida nce on public benefit
when reviewing the Society's aims and objectives cind in planning future activities. All the activities below are
for the public benef it.
The main activities undertaken in relation to the objects are to=
Provide facilities for the exchange of information, opinions, and experience about pain between
active workers in the f ield.
Increase awareness of pain prevalence, disability and pain management among healthcare and other
professiona Is and the pu bl ic.
Promote education and training in pai n management and research into the understanding and relief
of pain.
Institute or assist in instituting and provide continuing support for pain research.
Cause to be written, published, produced, and circulated, and to encourage contributions to and
publication and production of, periodicals, journals, books, papers, a bstracts, pam plilets, posters and
other document5 a nd films, videos, recorded tapes, and communications including learned journals,
mainstream print, broadcast a nd online media and social media platforms.
Endow Chairs, Readerships, Scholarships, Fellobvships and Lectu reships at, and provide other su pport
to, appropriate institutions to facilitate the conduct of study and research in furtherance of the
Objects.
Disseminate the useful results of research.
Sponsor and hold meetings, symposia, conferences, lectures, classes, seminars, courses, and
exhibitions either alone or with others.
Encourage and promote the study and research into aspects of pain. The Society offers four
bu r5aries/grants that are availa ble to its members: the" Clulow Research Award" the "Patrick Wall
I nternational Meetings Bu rsary" The British Pain Society Study Day Bursary" and the '1 nternational
Association for the Study of Pain World Congress Bursary" Full details of the awards, including
eligi bility and application forms, are availa ble on the Society website.
3. ACHIEVEMENTS AND PERFORMANCE
The Society continued to provide an educational pi'ogramme to increase the knowledge of pain management
to professionals and lay people within the rem it of the Memoranda and Articles of Association. Tlie Society
delivered the following series of meetings and pu blications:
Society Meetings/Events
The Annual Scientific Meeting 2024 was held between the 3 - 6 June 2024, Nottingham. A Public
Outreach activity was incorporated into the event and held at Nottingham Central library, providing
information to over 70 members of the public.
A webinar on "Placebo Controlled Trials in Surgery and Physica l or Psychological Pain Management" was
held on Iojanuary 2024.

THE BRITISH PAIN SOCIETY
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024
A webinar on "Chronic pain and the menopause/perimenopause" was held on 24 April 2024.
Awebinar on"Improving the Management of Children's Pain in Hospital" was held on 11 July 2024.
A webinar on "Towards more trustworthy pain research. The ENTRUST-PE framework" was held on 26
September 2024.
A webinar on "Music therapy for people with chronic pain" was held on 14 November 2024.
SIG Meetings/Events
The society held regu lar webinars covering a wide variety of educational topics..
In January 2024 the Philosophy and Ethics SIG held a webinar'The Global Opioid Crises and Why They
Matter to U K Clinicians"
In February 2024 the Philosophy and Ethics SIG held a webinar "Can creative activities together with
social connection be a legitimate part of a self-management plan?"
I n March 2024 the Philosophy and Ethics SIG held a webinar "Social prescribing and/or participation in
community assets for people living with chronic pain"
In April 2024 the Philosophy and Ethics SIG held a webinar"Revisiting pain"
In October 2024 the Philosophy and Ethics SIG held a webina r "Acupu ncture for Chronic Pelvic Pain"
In November 2024 the Philosophy and Ethics SIG held a webinar "On a Scale of One to Ten.. a personal
examination of the language of pain"
On 11 March 2024 the Older People SIG held a webinar"POPPY study & CARE75+ study"
The Primary and Community Care SIG held a webinar"Prescribing Forum: Pharmacological Management
of Neuropathic Pain" on 18 April 2024.
The Pain Management Programme SIG held a webinar"Pain management in the communit¢, on 16 May
2024.
The Primary and Community Care SIG held a webinar'mind your Flippin, Language" on 20June 2024.
The H eadache SIG held a webinar "Diagnosis and treatment and facial pain" on 4 July 2024.
The Primary and Community Care SIG held a webinar "Prescribing Forum.. So, should we ever prescribe
opioids?" on 18 July 2024.
The Primary and Community Care SIG held a webinar"PROMPPTStudy" on 24 October 20?4.
The Primary and Community Care SIG held a webinar "Integrating Supportive Self-management within
Services- Live Well with Pain" on 21 November 2024.
The society SIGS also held educational in-person events:
The Primary and Community Care SIG jointly with the Pain management programmes SIG held an in-
person study day on 3 June 2024 'Updates on Pain Rehabilitation Practice"
The Philosophy & Ethics Society SIG held their Summer Retreat in person 23- 26 Ju ne 2024.
Society Publications/Resources
The Society continues to provide its quarterly printed Newsletter 'Pain News, free of charge to its
members.
The Society continues to provide online access to its journ31 'British Journal of Pain, f ree of charge to its
members.
The Patient Voice Committee {TPVCI renamed themselves to the Expert Patient and Carer Committee.
They hosted a session at the ASM to provide an analysis of their Survey conducted in 2022, about pain
patients, routes into the Pain Clinic5, the im par.t of COVID-19 on their pain and accessing support through
pain services, self-management and the use of communiti, pain tea ms. They also presenttid the results
of their 2023 survey on pain medicines. Their presentation highlighted the irnportance of lived
experience in research.
The BPS contributed to the development of the UK Pain Messages which will be launched in 2024.

THE BRITISH PAIN SOCIErY
REPORT OF THE DIREcfoRS AND TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024
The BPS contributed to the development and u pdates of n umerous Patient Information Leaflets prepa red
by the Faculty of Pain Medicine, including '1 nformation for adult patients prescribed Non-steroidal Anti-
Inflammatory Drugs INSAIDS) for the Treatment of Pain,.
The BPS actively supported the promotion of 'Pain Awareness, month in September 2024 on the website
and all social media, plu5 weekly member emai Is with links to appropriate resources.
In collaboration with the Faculty of Pain Medicine, the BPS is actively involved in the development of a
credential for advanced practice th rough Health for England IHEEI.
The Communications Committee reviewed several publications, which were approved for endorsement
bythe BPS.
The BPS contributes, supports aid promotes e-PAIN" from e-Learning for Healthcare, which is a
multidisciplinary programme based on the International Association for the Study of
Pain's recommended multidisciplinary cu rriculum for healthcare professionals learning about pa in
management. e-PAI N is a collaboration between The Faculty of Pain Medicine, the British Pain Society
and e-Learning for H ealthcare. It is provided by Health Education England.
The Society continues to run surveys i n areas of iiiterest across its membership to gather evidence to
support projects and activities.
All the society's pu blications and patient information leaflets are available to download f ree of charBe
from the website.
The Society'5 social media presence on Twitter, Blue sky, I nstagram, Facebook and Linkedln continues to
grow.
In 2024, the Society continued to respond to requests from media for comment.
SIG Publications/Reiources
The Pain Management Programmes SIG completed a review and launched an update oil Guidelines for
Pain Management Programmes for adults.
The Pain Management Programmes SIG continues to update the PMP directory.
The Acute Pain SIG published a patient publication on Managing pain after surgery. Subsequently it has
been tra ns5ated i nto several languages (including Germa n, Dutch, Portuguese, Austra lian Eng5ishl and foi-
use in Southern Af rica.
The Society approved the a pplication for an Affiliate SIG for the Pa in N urse Network.
The Acute Pain SIG started work on a Patient Information Leaflet on prescribing opioids in ari acute
setting.
The BPS contributed to the update of the Opioids Aware Website led by the Faculty of Pain Medicine.
The u pdate will be released in 2025.
The BPS contributed to the u pdate of the Recommendations for Epidural Injections led by the Faculty of
Pain Medicine.
The BPS released Peri-operative pain management in adults.. a multidisciplinary consensus statement
from the Association of Anaesthetists and the British Pain Society.
The BP5 contributed to and released the UK Pain messages.
We will continue to review and update cu rrent guidelines and patient information leaflets.
Bursories & Grants
The Clulow Award wa5 last awarded in 2021- no award was granted in 2024 but will open in 2025.
Information for people offectod by pain
The Expert Patient and Carer committee formed the Lived Experience Collective, a diverse network of
individuals witli lived experience of pain. The LEC provides valuable insights to support the Britisli Pain
Society's work, helping to shape resources, inform advocacy efforts, and strengthen collaboration

THE BRITISH PAIN SOCIErY
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024
between healthcare professionals and those d irectly affected by pain. This initiative reflects the Society's
ongoing com m itment to ensuri ng that the voices of people living with pain are heard and integrated into
our activities.
The Expert Patient and Carer committee continue to inform on PPIE work and research.
The Society also continues to contribute and endorse patient information leatlets with other
organisations.
4. FINANCIAL REVIEW
Net def icit for the year as shown in the consolidated statement of f inancial resources was £67,66612023:
£13,907). The turnover of the trading subsidiary BPS Pain Business Ltd was £30.30012023.' £57,842). After
allowing for all related costs, a donation was made to the Society of £13,69912023.' £43,724).
The following is a summary of reserves at 31, December 2024:
Restritted funds..
Clulow legacy lincludi ng interest)
Other grants etc
PLC Seminar
116,744
307,028
834
Designated funds..
ASM
SIGS
100,334
102,553
General funds..
invested in fixed assets
Free reseNes
Total
1.181
222,136
850,810
The net SIG funds of £102,553 are designated within the Society accounts to further the activities of the
specific SIGS.
The Society continues to support its educational activities, including Special Interest Group Conferences and
a series of Study Days/Webinars. These meetings may be supported by unconditional educational grant5 or
sponsorship f rom various com panies, and for transparency the SIG activities are accounted for separately.
Reserve5
The Directors have reviewed the Society's needs for reserves in li ne with the guidance issued by the Charitv
Commission and have made the following provision..
to work towards £300,000 in general funds bei ng kept in reserve to cover the ongoing costs of the Society
should there be a failure of income.
Sustainable f inance5 remain an ongoing priority for the Society, a nd further work 15 needed to maintain and
strengthen this position. Cost management has been a significant focus and will be reflected in the 2025
budget. The principal sou rce of funding continues to be membership su bscriptions. However, the Directors
have recognised the importance of divers ifying income streams to ensure long-term financial resilience.

THE BRITISH PAIN SOCIETY
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024
The new Society strategy will set out a framework to explore and develop additional sources of income,
includi ng grants, partnerships, educational in itiatives, and fundraising activities, to su pport the Society's
mission and reduce reliance on membership fees alone.
Going Concern
The Directors continue to discuss its finances in detail at Council meetings, with the Executive Officers
meeting monthly frequently to discuss financial issues. In line with possible reduced income from the annual
conference, and the move of educational events to online, we have also looked at reducing the correspond ing
expenditu re. In 2025 the Society will:
Review membership structures and benefits to retain current members and attract new ones, including
early-career professionals, professionals who a re retired from practice and research, and international
affiliates.
Launch a sponsorship and partnerships policy to ensure consistent, values-aligned engagement with
external funders and collaborators.
Review income-generating opportunities, including workshop fees, exhibitor income, and digital content
offerings.
I nvest in operational efficiency, including financial management systems, to improve transparency,
reduce waste, and support data-driven decision-making.
These actions reflect the Society's commitment to long-term sustainability and resilience, ensuring that
resources a re directed toward its core objectives while safegua rding its futu re.
The Directors have confidence that the Society and the trading subsidiary have adequate resources to remain
in operation for 12 months after approval of these fi na ncial statement5.
5. PLANS FOR FUTURE PERIODS
The Society will carry out its strategic plan and priorities.
The Society will continue the project to develop a consensus statement on interdisciplinary working in
Inigraine with a grant f rom Pfizer.
The British Pain Society's 2025 Annual Scientific Meeting will take place as an in-person event between
3-5 June 2025. There are 3 education workshops taking place pre-ASM covering various topics:
Opioids in Clinical Practice (Organised jointly with the Acute Pain SIG and the Pain Nurse
Network)
Unlock the Future of Pain Management with Lifestyle Medicine: A Transformative Workshop foi.
Clin icians
o U Itrasound-guided Neck and Shoulder Intervention workshop
The society conti nues to expand its range of webinars, with several Special I nterest Groups ISIGSI also
running several webinars in 2025..
The role of Patient Education in Recovery from Persistent Pain.- A Neuroscience Perspective
Post Surgical Pain
what you need to know in 2025 (Joint webinar with the Association of
Anaesthetistsl
Pain management essentia Is.. What's 'out there, i n terms of education, su pport, resources, and
'training' for people who are experiencing pain?
How can basic scient15ts, healthcare professiona Is and patients i n the BPS work together for the
advancement of pain care?
o I ntegrating supportive 5elf-management into service51i'ointly with Live Well with Painl
Neurodiversity and persistent pain

THE BRITISH PAIN SoCI￿y
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024
Clinical Hypnosis Within I ntegrative Oncology
Is chronic pain telling us something important about society.
The Philosophy & Ethics SIG will commence planning fortheir annual meeting due to take place in June
2025.
The Headache 51G will begin planning a study day in October 2025.
BPS will expand the cu rrent suite of educational webinars and podcasts using the BPS events calendar
and regional champions to ensure health aiid social care professionals stay updated on the latest
knowledge and best practices in pain management.
BPS will open to receive applications ,'or the Clulow Award in 2025
BPS will develop research priorities in pain management and promote them.
BPS is reviewing the introduction of initiatives such as small grants and student prizes to su pport research
by early-career professionals.
BPS is working towards how best to create a collaborative forum to share best practices, successful
quality improvement initiatives, and lessons learned to drive continuous, equity-focused enhancements
in pain management.
BPS will stablish buddy systems, remote mentorship programs, and peer support networks to offer
continuous professional su pport, guidance, and development for those working in pain care.
6. STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
SO far as the Directors are aware, there is no releva nt audit information of which the compa ny'5 auditors are
unaware, and each Director has taken all the steps that they ought to have taken as a Director to make
themselves aware of aiiy relevant audit information a nd to establish th.at the compaiiy's auditors are aware
of that information.
7. STATEMENT OF DIRECTORS, RESPONSIBIUTIES
Cornpany law requires the Directors land also its Trustees foi the purposes of Charity lawl to prepare financial
statements for each financial year which gives a true and fair view of the state of affairs of the charitable
company and of the incoming resou rces and application of resou rces, i ncluding the income and expenditure,
of the charitable company during that period. In preparing those financial statement5 the Directors are
requ ired to..
Select suitable accounting policies and then apply them consistently.
lill Observe the methods and principles in the Charities SORP.
liiil Make judgement5 and estimates that are reasonable a nd prudent.
livl State whether applicable UK Accounting Standards have been followed, subject to any material
departures disclosed and explained in the financial statement5.
Iv) Prepare financial statements op a going concern basis unless it is inappropriate to presume that the
companywill continue in business.
The Directors are responsible for keeping proper accou nting records which disclose with reasonable accuracy
at any time the firiancial position of the charitable company and to enable them to onsure that thefinancial
statements comply with the Companie5 Act 2006, the Charities and Trustee Investment (Scotlandl Act 2005
and the Charities Accounts (Scotlandl Regulations 2006 las amended). They are a150 responsible for
safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention
and detection of fraud and other irregularities.
io

THE BRITISH PAIN SOCIETY
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024
In prepdring this report the Directors have taken adva ntage of special provisions of the Companies Act 2006
relating to small companies.
Signed:
Dated..
203
Dr Neil Collighan IHonorary Treasurer)
li

THE BRITISH PAIN SOCIErY
INDEPENDENT EXAMINER'S REPORTTO THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2024
I report to the charity Tru.5tees on my examination of the accounts of the company for the year ended
31 December 2024, which are set out oli pages 13 to 26.
Responsibilities and basis of report
A5 the charity Trustees of the company la nd also its Directors for the purposes of company lawl you
are responsible for the preparation of the accounts in accordance with the requirements of the
Companies Act 20061'the 2006 Act'l.
Having satisfied myself that the accounts of the company are not required to be audited under Part 16
of the 2006 Act and are eligible for independent examination, I report in respect of my examination of
you r compa ny's accounts as carried out under section 145 of the Cha rities Act 20111'the 2011 Act'l. I n
carrying out my examination I have fo15owed the Dirertions given by the Cha rity Commission u nder
settion 145151 Ibl of the 2011 Act.
Independent examinerfs statement
I have completed my examination. I confirm that no matters have come to my atte.ntion in connection
with the exan)ination giving me cause to believe that in any material respect..
Accounting records were not kept in respect of the company as required by section 386 of the 2006
Act,. or
The accoLI nts do not accord with those records; or
The accounts do not comply with the accounting requirements of section 396 of the 2006 Act other
thari any requirement that tha accounts give a 'true a nd fair view, which is not a matter cons idered as
part of an independent e.xamination- or
The acLounts have not been prepared in accordance with the methods ènd principles of the Statement
of Recom mended Practice for accounti ng and reporting by charities lapplicable to charities prepari ng
their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic
of Ireland IFRS 10211.
I have no concerns and have come across no other matters in connection with the examination to
which attention should be drawn in this report in order to enable a proper understanding of the
account5 to be reached.
Signed..
Dated.. 251
M J Cridland BA (Honsl FLA
Scott Vevers Ltd
Chartered Accountant5 & ReE15tered Auditor5
65 East street
Bridport
Dorset
DT6 3LB
12

THE BRITISH PAIN SOCIETY
CONSOLIDATED STATEMENT OF FINANCIAL AcfiviTIES
(including consolidated income and expenditure account)
FOR THE YEAR ENDED 31 DECEMBER 2024
Unrestricted Restricted
Funds
Funds
TOTAL
TOTAL
2023
Notes
2024
Income from:
Donations and legacies
111,630
111,630
118,440
Income f rom charitable activities
33,939
33,939
40,580
Incomefrom other trading octivities
Commercial trading operation5
30,300
30,300
57,842
Investment income-intiirest received
17,828
17,828
18,332
Total income
193,697
193,697
235,194
Expenditure on.
Roising Fund5
Commercial trading operations
4,581
4,581
5,100
Charitable activities
256,782
:)6,782
244,001
Total Expenditure
261,363
261.,363
249,101
Net income/lexpenditurel for the year
(67,666)
(67,666)
(13,907)
Gross transfers between funds
Net movement in funds
(67,666)
(67,666)
(13,907)
Reconciliation of funds-
Total Funds at ljanuary 2024
493,870
424,606
918,476
932,383
Total Funds at 31 December 2024
426,204
424,606
850,810
918,476
All amounts derive frorn contiriuinB activities.
All Eains and losse5 recognised in the period are included in the statement of financial activities.
The notes on pages 16 to 26 form part of these tinancial staiements
13

Cornpany Registration Nufnber.. 5021381 (England Walesl
THE BRITISH PAIN SOCIETY
BALANCE SHEETS
AS AT 31 DECEMBER 2024
Consolidated
2023
Charity
Note
2024
2024
2023
Fixed a55ets
Tangible assets
Investments
12
13
1,181
1,879
1,181
1,879
1,181
1,879
1,182
1,880
Current assets
Debtors
Cash at bank and in hand
14
4,606
960,521
15,265
1,063,405
14,168
948,498
89,287
985,699
Total current assets
965,127
1,078,670
962,666
1,074,986
Creditors: amounts falling due
within one year
15
(115,498) (162,073)
(114,138) (159,490)
Net Current assets
849,629
916,597
848,528
915,496
Net assets
850,810
9l8,476
849,710
917,376
Funds of the charity
Restricted iiicotTie funds
16
424,606
424,606
42a 606
4?4,606
unre.stricted incomefunds..
Designated funds
General funds
202,887
223,317
426,204
242,956
250,914
493,870
202,887
222,217
4£.5,104
?42,q56
249,814
492,770
Total charity funds
850,810
918,476
849,710
917,376
The Directors have preparp.d group accounts in accordance with section 398 of the Companies Act 2006, tlie
Charities ALt 2011 and seLtion 44 of the Charities and Trustee Investment Isrotlandl Act 2005. These
account) are. prepared in accordance with the special provisions of Part 15 of the co￿lp￿￿ ies p.ct relating to
small companies.
For the financial year in question. the coinpany is entitled to exemption from audit under Section 477 of the
Companies Act 2006 relatiig to sniall companies.
Tlie members have not required the compaiiy to obtain a17 audit of its financial Statements for the ¥ear iii
questiori in accordarice witli Section 476 of tlle Conipanief Act 2006.
The Directors acknowledge their responsibilities for com plying with the requirenient5 of tlie Companies Act
2006 with respect to accounting records and the preparatioii of ac.counts.
The finaiicial statements wei'e approved by the Directors on
Signed or, their behalf by
Dr N Collighan- Honordry Treasurpr
Tne notes on page.s 16 to 26 form part of these financi31 stit teiTpiits
14

THE BRITISH PAIN SOCIETY
STATEMENT OF CASH FLOWS AND CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
Consolidated
2024
2023
Charity
2024
2023
Net cash flow from operating activities
1120,7121
13,270
155.0291
145,4011
Cash flow from investing activities
Interest received
17,828
18,332
17,828
18,332
Net cash flow from investing activities
17,828
18,332
17,828
18,332
Cash flows from financing artivities
Net increase/ldecrease) in cash and cash
equivalents
1102,8841
31,602
137,2011
127,0691
Cash and cash equivalents at l January 2024
1,063,405
1,031,803
985,699
1,012,768
Cash and cash equivalents at 31 December 2024
960,521
1,063,405
948,498
985,699
The notes uii pages lty to 26 form part of these financial statements
15

THE BRITISH PAIN SOCIErY
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
l General information
The Charity is a company limited by guarantee incorporated in England and Wales under the Companies Act
2006 and Charities Act 2011. The address of the registered office is provided in legal and administrative
details. Details of the Charitrfs operations are provided in the Report of the Directors. The lia bility in respect
of the guarantee is limited to £1 per member of the Charitv.
2 Accounting policies
The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the
preparatioii of the financial statements are as follows..
a) Basis of preparation
The financial statements b.a4e been prepared in accordance with Accounting and Reporting by Charities
Statement of Recommended Practice applicable to charities prepariiig their accounts in accordance with the
Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS1021- (Charities SORP IFRS
10211, the Charities Act 2011, section 44 of the Chtirities and Trustee Investment (Scotlandl Act 2005 and the
Companies Act 2006.
The British Pain Society meets the definition of a public benef it entity under FR5 102. Assets and liabilities are
initially recognised at historical cost or transaction value unless otherwise stated in the relevant policy note.
b) Accountlng convention
The financial statements have been prepared on a going concern basis as the Trustees believe that no
material uncertainties exist. The Trustees have considered the Sevel of funds held a nd the expected level of
incoine and expenditure for 12 months from authorising these fiiiancial statements. The budgeted income
and expenditure is sufficient with the level of reserves for the Chai'ity to be able to continue as a going
concern.
c) Basis of consolidation
The financial statements consolidate the results of the Charity and its wholly owned subsidiary BPS Pain.
Business Ltd on a line by line basis. The accounting year ends are coterm inous. The parent Chai'ity has taken
advantage of section 408 of the Companies Act 2006 not to include an individual income aiid expenditure of
its results.
d) Income
All incoming resource5 are included on the Statement of Financial Activities when the Charity is legally entitled
to the income, it is probable the income wil I be received and the amount can be quantified with reasonable
accuracy.
Membership subscription periods commence on 1st November each year and therefore the recognition of
subscription iiicome received in advance is deferred.
Interest on funds held on deposlt is included when receivable and the amount can be measured reliably by
the Charity.
el Donated services and facilities
Donated professional service5 and donated facilitie5 are recognised as income when the Charity has control
over the item, ariy conditions associated with the donated item have been met, the receipt of economic
benefit from the use by the Charity of the item 15 probable and that economic benefit can be measured
reliably. In accordance with the Charities SORP (FR5 1021, general volunteer time is not recognised.
Inforination on the contribution of Directors is given in the annual report. On receipt, donated professional
services and donrlted facilities are recognised on the basis of the value of the gift to the Charityi which is the
amount the Charity would have been willing to pay to obtain services or facilities of equivalent ecoiiomic
benefit on the open market; a corresi)onding amount is then recognised in expenditure in the period of
receipt.
16

THE BRITISH PAIN SOCIETY
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
2 Accounting policies (continued)
f) Expenditure
Expenditure is accounted for on an accruals basis aiid has been classified under heading5 that aggregate all
cost related to the category. Where costs cannot be directly attributed to particular headings they have been
allocated to activities on a basis consistent with the use of resources. Grants offered subject to conditions
which have not been met at the year end date are noted as a commitment but not accrued as expenditure.
gl Fund accounting
Unrestricted funds are available to spend on activities that further any purposes of the Charity. Designated
funds are unrestricted funds of the Charity which the Trustees have decided at their discretion to set aside to
use for a specific purpose. Restricted funds are doiiations which the donor has specif led are to be solely used
for particular areas of the Society's work or for specific projects being undertaken by the Society. Further
explanation OF the nature dnd purpose of each fund is included in the notes to the financidl statements.
h) Tangib5e fixed assets
Tangible fixed assets are stated at cost le55 depreciation. Assets costing less than £500 are written off in the
yedr of purchase. Depreciation 15 provided at the following annual rate5 in order to write off each asset over
its estimated usefu5 life as folluws..
Office Equipment - 5 years straight line
Fixtures and Fittings 5 years straight line
Change in Accounting Pollcy- Depreciation rate
During the year, the Charity reviewed the pattern of consumption of economic benefits associated with its
tangible fixed assets. As a result, the Charity chaiiged the depreciation method applied to the asset from
25°A reducing balance metho(1 to 5 vears straight line method.
The Trustees consider that depreciating the assets over 5 years reflects the expected usage pattern and future
economic benefits of the asseis.
This change in accounting policy ha5 been applied prospectiveSy from l January 2024 in accordance with FRS
102 Section 10.16. The impact of the change in the current financial year 'Nas a dpcrease in depreciatian
expense of £81 and assets with the net book value of £403 being written off.
Prior period figures have not been restated.
l) Operating leases
Rental charges payable under operating leases are charged on a straight line basis over the terms of the lease.
j} Financial instruments
Classification
Financial assets and financial liabilities are recognised when the Charity becomes a party to the contractual
provision5 of the instrument.
Financial liabilities and equity instruments are cla55ifie,d according to the substance of the contractual
arrangement entered into. An equity instrument is any contract that evidences a residual interest in the
asset5 of the Chhrity after dedLlCting all of it5 liabilitie5.
Recognition and measurement
All financial assets and liabilities are initially measured at transaction price lincluding transaction costsl,
except for those financial assets classified as at fair value through profit or105s, which are initially measured at
fair value Iwhich is normally the transaction price excluding transaction costs), unless the arrangement
constitutes a financing transactions. If an arrangemeyt constitutes a financing transaction, the financial asset
or financial liability Is measured at the present value of the future payments discounted at a market rate of
interest for similar debt instrumeiit.5.
Financial a55ets and liabilities are orily offset in the Statement of financial position when, and only when there
exists a legally enforceable right to set off the rei:ognised amounts and the Charity intends either to settle on
a net basis, or to realise the asset and settle the liability simultaneousl'¢.
17

THE BRITISH PAIN SOCIEri
NOTE5 TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
Accounting policles {continuedl
j) Financial instruments
Financial assets are derecognised when and only when al the contractual rights to the cash f lows from the
financial asset expire or are settled, bl the Charity transfers to another party substantially all of the risks and
rewards of ownership of the financial asset, or cl the Charity, despite having retained some, but not all,
significant risks and rewards of ownership, has transferred control of the asset to another party.
Financial liabilities are derecognised only when the obligation specified in the contract is discharged, cancelled
or expires.
Financlal performance of the Charity
A summary performance of the Charity excluding the results of its wholly owned subsidiary is:
2024
2023
163,397
12,020
13,699
189,116
256,782
(67,666)
177,352
6,550
43,724
227,626
244,001
(16,375)
Incoming resou rces
Income from subsidiary company paid under licence
Donation of profits under gift aid
Expenditure on charitable activities
Net expenditure
4 Income from donations and legacies
2024
2023
2,604
109,026
111,630
583
117,857
Donations
Subscriptions
Income f rom charitable artivities
2024
2023
16,680
17,259
33,939
26,720
13,860
40,580
SIGS
Other income including royalties
18

THE BRITISH PAIN SOCIETY
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
Other trading activities - BPS Pain Busine55 Ltd
2024
2023
Income generated by BPS Pain Business Ltd
30,300
57,842
BPS Pain Business Ltd Iregistered in Engla nd and Wales, com pany no. 92200781 is the Charity's wholly owned
subsidiary. It operates the trade exhibition at the anriual scientific meeting, and other trading activities, under
licence from the Charity. The results of the company for the year were as follows-_
2024
2023
Turnover
Cost of sales and administration costs
Costs recharged by the Charity under licence
Profit
Donation under gift aid to The British Pain Society
Retained in subsidiary
Aggregate assets
30,300
{2,177)
(14,424)
13,699
(13,699)
57,842
(5,100)
(6,550)
46,192
(43,724)
2,468
I,ioi
I,ioi
19

THE BRITISH PAIN SOCIETY
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
Expenditure on charitable activitie5
2024
2023
Staff costs
Direct costs
Support costs
Governance costs
195
124,810
107,365
11,631
244,001
201,432
49,265
6,085
256,782
2024
2023
Direct costS.-
Research grants
ASM costs
Other meeting costs
Newsletter and Journal
iioi
10,030
71,061
43,729
124,810
37,342
126,880
37,210
201,432
Support C05ts.'
Property costs
Office costs
C.ompute." 5ySteni and software
Insurance
Doubtful deb4S
Accountancv
Depreciation
Loss on disposal of asset5
Legal and professional fees
24,097
16,561
1,143
466
66,847
15,053
5,032
3,001
12, 1861
9,355
469
1,360
8,434
107,365
295
403
6.300
49,26)
Governance costs..
Council expense5
Induction and training of Trustees
Indeppiident exam ination
Annual report
3,716
60
2,295
14
6.085
8,919
2,712
11.631
Net income/(expenditure) for the year
This is stated after charging..
2024
2023
Depreciation
Operating lease payment5
Independeilt Examiner's remuneration..
Accountancy Services
Independent Exarnination Fees
295
469
12,959
15,000
1,355
940
1,592
I,l20
20

THE BRITISH PAIN SOCIFri
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
9 Grant5
The attached annual report details the grants offered by the Charity.
The Clulow Award:
The award is awarded bi-annually lup to a maximum of £50,000), and is paid in four instalments at agreed
milestones. The first three instalments will be paid at 30°A of the total invoice from the receiving institution.
The first In5talment will be transferred following receipt of the signed grant value and the foijrth at IO°A, each
against an award letter. The second and third instalments will be paid on receipt and approval by The British
Pain Society of two progress reports to be subm itted at 12 and 18 months from the date of receipt of grant
award letter. A final instalment of IO% will be paid upon receipt of the study final report.
Patrick Ivall International Meetings Bursarv..
The Society has made funds available to assist scientists, clinical or allied hea5th practitioners at the earlv
stages of their careef in pain research who require financial assistance to present their work at overseas
scientific meetings, other tPian the British Pain Society's Annual Scientific Meeting and the IASP World
Congress (separate bursaries are available for these two meetings).
The Pfizer grant..
The grant was received to support a projett intended to promote interdisciplinary working in the assessment
and treattTient of migraine. The aim is to look at ways to improve treatment for people suffering with
migraine by providing timely access to specialists to have a diagnosis and a pei"sonalised rnanagemLJnt plan
which could be implemented through other primary and secondary care services.
2024
2023
Clulow award cost..
(io)
(io)
Total grants and bursarie5 awarded..
During the year this event was wholly outsourced to Kenes International Organizei-s of Congresses SA. A
summary performance of the annual conference..
2024
2023
Incoming resources
Expenditure incurred
Net income / (expenditure}
262,791
268,284
(5,493)
268,100
245,114
22,986
The Society also had direct Annual Scientific Meeting activity in the year which is sumniarised on note 16.
10 Analysis of Staff costs and council expense5
No Charity trustee received a salary, benefits or any other payment for services supplied to the Charity12023'.
6 Trustees were reimbursed expenses, including those of attending the A5M during the year of £2,43612023:
13 Trustee5 £6,080).
The total cost of runniiig the council excluding ASM c05t5 was as follows..
2024
2023
Meetiri8- Room Hire / Catering
Meeting Travelling
964
2,752
3,716
2,373
4,042
6,415
21

THE BRITISH PAIN SOCIE
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
11 Corporation tax
The Charity is exempt from tax on income and gain5 falling within section 505 of the Taxes Act 1988 or section
252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.
12 Tangible fixed assets (Group and Charity)
Office
Equipment
Fixtures &
Fittings
Total
Cost..
As at lJanLiary 2024
Disposals
As at 31 December 2024
3,540
(1,744)
1,796
8,214
(6,721)
1,493
11,754
{8,465)
3,289
Depreciation:
As at l January 2024
Charge for the year
Disposals
As at 31 December 2024
2,428
112
(1,496)
1,104
7,447
123
(6,566)
1,004
9,875
295
(8,062)
2,108
Net book value:
As ar 31 Derember 2024
692
4813
1,181
As at 31 DLcember L023
761
1,879
13 Flxed asset Investment
Group
Charity
2024
2023
2024
Wnolly Ovoned subsidiary
BPS Pain Bus5ness Ltd= l ordinary share of £1
14 Debtors
Group
Charity
2024
2023
2024
2023
Operational invoices
Amounts owed by gi'oup undertakings
Prepayments
Other dehtors
7,80U
9,562
3,982
624
81,822
4,363
3,102
89,287
3,982
624
4,363
3,102
4,606
14,168
22

THE BRITISH PAIN SOCIErf
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
15 Creditors: amount5 falling due within one year
Group
Charity
2024
2023
2024
2023
Trade creditors
Subscriptions advanced payments
Other creditors
Accruals for grants payable
Accruals
Taxation and VAT
1,798
83,942
234
19,855
4,289
5,380
115,498
47,377
73,800
4,564
30,000
6,250
82
1,798
83,942
234
19,855
2,929
5,380
114,138
45,936
73,800
4,564
30,000
5,190
162,073
159,490
16 Analysis of charitable funds
Net
Balance
01.01.24
31.12.24
Income Expenditure
income
Transfers
2024
Restricted funds
Clulow legacv
Graiits
PLC Seiyiiriar
116,7
307,028
834
116,744
307,028
834
424,606
424,606
Designatpd funds
SIGS
Map of Iv1edicine Pathways
ASM
16,680
(11,633)
5,047
97,506
7,7/4
137,676
242,956
102,553
(7,774)
(37,342)
(48,975)
(37,342)
(32,295)
100,334
202,887
16,680
(7,774)
General fund
146,717 (207,807)
163,397 (256,782)
(61,090)
(93,385)
33,493
249,814
222,217
849,710
Total éunds of the Charity
25,719
917,376
BPS Pain Business Ltd
30,300
(4,581)
1261,3631
25,719
167,6661
(25,719)
I,ioo
I,ioo
Total funds
193,697
918,476
850,810
23

THE BRITISH PAIN SOCIETY
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
16 Analysis of charitable Aund5 (continued)
Net
income
Balance
01.01.23
31.12.23
Income
Expenditure
Tran5fer5
2023
Restrictedfunds
Clulow legacy
Gronts
PLCSeminar
io
io
116 734
307,028
834
116 744
307,028
834
io
io
424,596
424,606
Designutedfund5
SIGS
Mop of Medicine Pothways
ASM
47,489
(23,968)
23,521
[17,588)
91,573
7,774
145,952
97,506
7,774
137,676
(8,276)
(32,244)
[8,276)
15,245
47,489
(17,588)
245,299
242,956
Generolfund
Totolfunds of the Chority
129,863 (211,767)
177,352 (244,001)
(81,904)
(66,649)
67,862
50,274
263,856
933,751
249,814
9J7,376
BPS Pain 811siness Ltd
57,842
(5,100)
235,194 (249,101)
52,742
(13,907)
(50,274)
(1,368)
932,383
I,ioo
918,476
Totalfund5
Details of restricted funds
Clulow Legacv
A legacy was received from Mildred B and Elaine Clulow for '8asic research into the causes and cures for
pain
Grants
In 200812009 grants were received from industry to support the development of d Primary Care initiative to
produce a range of GP/primary care resources.
In 2022 8 grant was received from Pfizer to support a projert intended to promote interdisciplinary workiiiE in
the assessment and treatment of Migraine.
PLCSeminar
In 2016 a restricted grant for the work of the Patient Liaison Committee was received. In auTreement with the
funder, the grant was agreed to be used to support the provision of an annual 'Professor Sir Michael Bond
Lecture, aimed at topics relevant to people living with pain.
Details of designated f unds
SIGS
The Directors have set aside the accumulation of surpluses from meetings over several years to be spei",t on
the work of individual special interest groups as detailed in the annual report. In 2020 the Society introduced
a nominal membership fee for it's SIGS. The membership fees are designated for the individual special interest
groups.
ASM
The Designated A5M Funds are accumulation of surpluses from meeting5 over several years and are to be
spert on education and research.
24

THE BRITISH PAIN SOCIETY
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
17 Analysis of net as5et5 between funds
Consolidated
General
Designated Unrestricted Restricted
Total
Total
2024
Fixed assets
Current assets
Creditors.. amount5 falling due within
one year
1,181
317,779
1,181
520,666
1,181
965,127
202,887
444,461
(95,643)
(95,643)
(19,855)
(115,498)
Net 35sets
223,317
202,887
426,204
424,606
850,810
2023
Fixed assets
Current assets
Creditors.. amountsfalling due within
one year
1,879
381,108
1,879
624,064
1,879
1,078 670
242,956
454,606
(132,073)
{132,073)
(30,000) (162,073)
Net assets
250,914
242,956
493,870
424,606
918,47
Charity
2024
Fixed assets
Currerit aqsets
Creditors.. amounts falling due within
one yedl.
1,182
315,318
1,182
518,205
1.18?
962,666
202,887
(94,283)
(94,283)
(19,855)
(J.14, 138)
Net assets
222,217
202,887
425,104
424,606
849,710
2023
Fixed assets
Curient 055ets
Creditors.. umountsfalling due within
one year
1,880
377,424
1,880
620,380
1,88LI
1,074,986
242,956
454,606
(129,490)
(129,490)
(30,000) [159,490)
Net a55et5
249.814
242,956
492,770
424,606
917,376
18 Gross obligation5 under operating leasing agreements
As at 31 December 2024 the group had future minimum lease commitments B5 follows..
2024
2023
Total
Total
Not later than l year
Later than l year and not later than 5 years
15,000
13,750
28,750
15,000
28,750
43,750
25

THE BRITISH PAIN SOCIEr
NOTE5 TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
19 Reconciliation of net movement in funds to net cash flow from operating artivities
Group
Charity
2024
2023
2024
2023
Net movement in funds
Add back.. depreciation charge
Add back.. loss on disposal
Interest received
Decrease/lincreasel in debtors
Increase/ldecreasel in creditors
Net cash used in operating activities
(67,666)
295
403
(17,828)
10,659
(46,575)
(120,712)
(13,907)
469
1,360
(18,332)
(10,899)
54,579
13,270
(67,666)
295
403
(17,828)
75,119
(45,352)
(55,029)
(16,375)
469
1,360
(18,332)
(68,674)
56,151
(45,401)
20 Finantial instruments
Categorisation of financial instruments
Group
Charity
2024
2023
2024
2023
Financial assets that are debt instrument measured
at amortised cost
961,145
115,498
1,074,307
162,073
958,684
114,138
1,070,623
159,490
Financial liabilities measured at amort15ed cost
Items of income, expense, gains or losses
The total interest income for financial assets not measured at fair value through profit or loss is £17,828
1202.3.. £18.3321.
26